Profil

Ansciaux Emilie


Main Research Fields
Radiology, nuclear medicine & imaging
Chemistry
Pharmacy, pharmacology & toxicology
Immunology & infectious disease
Neurology
Main Keywords
Alzheimer's disease; molecular imaging; amyloid peptide; iron oxide nanoparticles; neurodegenerative disease;
Main Unit & Research Centers
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale
Main Co-authors
Vander Elst, Luce 
Burtea, Carmen 
Laurent, Sophie 
Muller, Robert 
Nonclercq, Denis 

Publications (total 12)

The most cited
28 citations (SCOPUS)
Larbanoix, L., Burtea, C., Ansciaux, E., Laurent, S., Mahieu, I., Vander Elst, L., & Muller, R. (06 May 2011). Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease. Comparison with two cyclic heptapeptides derived from a randomized phage display library. Peptides, 32(6), 1232-1243. doi:10.1016/j.peptides.2011.04.026 https://hdl.handle.net/20.500.12907/27062

Ansciaux, E., Burtea, C., Laurent, S., Crombez, D., Nonclercq, D., Vander Elst, L., & Muller, R. (05 June 2015). In vitro and in vivo characterization of several functionalized USPIO vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Contrast Media and Molecular Imaging, 10 (3), 211-224. doi:10.1002/CMMI.1626
Peer Reviewed verified by ORBi

Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., Nonclercq, D., & Muller, R. (13 June 2014). Un agent de contraste vectorisé contre les plaques amyloïdes et potentiellement capable de franchir la barrière hémato-­encéphalique : vers un diagnostic précoce de la maladie d'Alzheimer par imagerie de résonance magnétique. Paper presented at 12ème Réunion Francophone sur la Maladie d'Alzheimer et les syndromes apparentés, Montpellier, France.

Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., Nonclercq, D., & Muller, R. (10 February 2014). A contrast agent vectorized against amyloid plaques and potentially able to cross the blood-­brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Poster session presented at Belgian Peptide Meeting, Ghent, Belgium.

Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (26 May 2013). A contrast agent vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Paper presented at 8th Annual Meeting of the European Society of Molecular Imaging, Torino, Italy.

Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (24 May 2013). USPIO-PHO: a new vectorized contrast agent for early Diagnosis of Alzheimer's disease By molecular imaging. Poster session presented at 1st Health Institute Day, Mons, Belgium.

Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (06 March 2013). Alzheimer's disease : new promising vectorized contrast agents for early diagnosis and evaluation of future therapeutic strategies using magnetic resonance imaging. Paper presented at International Congress Alzheimer's Disease/Parkinson's Disease 2013, Florence, Italy.

Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (29 January 2013). Alzheimer's disease : new promising vectorized contrast agents for early diagnosis and evaluation of future therapeutic strategies using magnetic resonance imaging. Poster session presented at Journée Scientifique des Doctorants en Sciences biomédicales et pharmaceutiques; New tools and strategies in the identification of pathology-related biomarkers, Mons, Belgium.

Ansciaux, E., Burtea, C., Vander Elst, L., Laurent, S., & Muller, R. (17 June 2012). Développement de nouveaux agents de contraste vectorisés destinés au diagnostic par IRM de la maladie d'Alzheimer. Poster session presented at Doctoriales Franco-Belges, Mont Saint-Aubert, Belgium.

Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (22 May 2012). Développement de nouveaux agents de contraste vectorisés destinés au diagnostic par IRM de la maladie d'Alzheimer. Poster session presented at 11ème Réunion sur la Maladie d'Alzheimer et les Symptomes Apparentés, Toulouse, France.

Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (06 October 2011). In vitro and in vivo characterization of several functionalized USPIO derivatives designed for molecular MRI of Alzheimer's disease. Poster session presented at 28th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Leipzig, Germany.

Larbanoix, L., Burtea, C., Ansciaux, E., Laurent, S., Mahieu, I., Vander Elst, L., & Muller, R. (01 June 2011). Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Peptides, 32 (6), 1232-43. doi:10.1016/j.peptides.2011.04.026
Peer Reviewed verified by ORBi

Larbanoix, L., Burtea, C., Ansciaux, E., Laurent, S., Mahieu, I., Vander Elst, L., & Muller, R. (06 May 2011). Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease. Comparison with two cyclic heptapeptides derived from a randomized phage display library. Peptides, 32(6), 1232-1243. doi:10.1016/j.peptides.2011.04.026
Peer Reviewed verified by ORBi

Contact ORBi